Cynomolgus Monkey Lung Subcellular Fractions
View ProductsDESCRIPTIONPACKAGINGCHARACTERIZATION PROVIDEDRELATED PRODUCTSSAFETY, HANDLING AND STORAGEPRODUCTSDESCRIPTION
As the primary site for the entrance of airborne agents, and as the recipient of all cardiac output, the lungs may provide both first-pass and systemic metabolism of xenobiotics through several enzymatic pathways, including both cytochrome P450 and Phase 2 enzymes.
Return to TopPACKAGING
MicrosomesConcentration: 10 mg/mL
Suspension buffer: 250 mM sucrose
S9 fractionConcentration: 5 mg/mL
Suspension buffer: 50 mM TRIS
·HCl (pH 7.4 at 4°C) containing 150 mM KCl and 2 mM EDTA
Return to TopCHARACTERIZATION PROVIDED
- NADPH-cytochrome c reductase
- 7-Ethoxyresorufin O-dealkylation
- 4-Methylumbelliferone glucuronidation
Return to TopXenoTech also offers subcellular fractions of pulmonary tissue from the following toxicologically significant species:
Return to TopSAFETY, HANDLING AND STORAGE
Policy statement concerning the safety of non-human primate-derived material
XenoTech manufactures products derived from non-human primate tissue for the purpose of xenobiotic research.
All tissue used to manufacture these products is obtained from reliable sources within the
United States, and is obtained from disease-free (asymptomatic) animals under the care of a veterinarian.
In accordance with federal (USDA) regulations, all non-human primates entering the
United States are placed in quarantine for a period of thirty days.
If an animal is infected with Ebola virus, it would die during the quarantine period, and hence, would not reside in a primate colony in the
United States.
For this reason, Ebola virus testing is not a common procedure in the
United States.
Animals are tested for Simian Herpes B virus (SBV), Simian Retrovirus (SRV), and Simian Immunodeficiency virus (SIV).
All non-human primate tissue utilized at XenoTech is obtained from animals which have tested seronegative for these viruses.Although animals are quarantined and tested for certain infectious diseases, it is not scientifically possible to guarantee that non-human primate-derived material is free of
all infectious agents and poses absolutely no health risk.
Therefore, we strongly caution all researchers who use non-human primate-derived material to treat such material as a potential biohazard, and to observe all national, regional, and local regulations governing the handling of such material.
Even if non-human primate-derived material has been tested for the presence of specific infectious agents by highly sensitive techniques, such as PT-PCR, and found to test negative, the material should still be treated as a potential biohazard.
PRODUCTS
Product No. |
Product |
Gender |
Amount |
P2000.P |
Pooled Cynomolgus Monkey Pulmonary Microsomes |
Male |
0.5 mL at 10 mg/mL |
P2000.PS9 |
Pooled Cynomolgus Monkey Pulmonary S9 Fraction |
Male |
1.0 mL at 5 mg/mL |
Return to TopOrder Fax: 913.227.7171
Order E-mail: info@xenotechllc.com
Call 877.588.7530 (toll-free US and Canada) for pricing and availability.
If ordering outside of North America, please see our Distributor information.